Opportunity

DIBBS #SPE2DP-26-T-4457

DLA Solicitation for Gabapentin Capsules from Approved OEMs

Posted

August 04, 2026

Respond By

August 10, 2026

Identifier

SPE2DP-26-T-4457

NAICS

424210

The Defense Logistics Agency (DLA) is seeking offers for the supply of Gabapentin Capsules under NSN 6505-01-387-1892. - Government Buyer: - Defense Logistics Agency (DLA) - OEMs/Approved Manufacturers: - Marlex Pharmaceuticals Inc (part number NDC10135-0644-01) - Cipla USA Inc (part number NDC69097-0813-07) - Sciegen Pharmaceuticals Inc (part number NDC50228-0179-01) - Products Requested: - Gabapentin Capsules - NSN: 6505-01-387-1892 - Total quantity: 7 units - Split across three approved manufacturers/part numbers - Notable Requirements: - Only products from the listed approved manufacturers/part numbers are acceptable - The solicitation is designated as a 'Fast Award' opportunity - No unique technical or performance requirements beyond sourcing from approved OEMs - No services are requested in this solicitation

Description

GABAPENTIN CAPSULES (QTY: 2, NSN: 6505-01-387-1892, Purchase Request: 7016615962) Approved Sources: - CAGE: 1TAP7, Part No: NDC10135-0644-01, Company: MARLEX PHARMACEUTICALS INC - CAGE: 7WV84, Part No: NDC69097-0813-07, Company: CIPLA USA INC - CAGE: 8NLP1, Part No: NDC50228-0179-01, Company: SCIEGEN PHARMACEUTICALS INC

GABAPENTIN CAPSULES (QTY: 5, NSN: 6505-01-387-1892, Purchase Request: 7016153280) Approved Sources: - CAGE: 1TAP7, Part No: NDC10135-0644-01, Company: MARLEX PHARMACEUTICALS INC - CAGE: 7WV84, Part No: NDC69097-0813-07, Company: CIPLA USA INC - CAGE: 8NLP1, Part No: NDC50228-0179-01, Company: SCIEGEN PHARMACEUTICALS INC

View original listing